Business

Aphex BioCleanse System Inc Suspends Director Scott Smith

Aphex BioCleanse System Inc Suspends Director Scott Smith.

articleSunset Capital Assets, Inc.March 4, 20225/news/aphex-biocleanse-system-inc-suspends-director-scott-smith
Aphex BioCleanse System Inc Suspends Director Scott Smith

About this update from Sunset Capital Assets, Inc.

PITTSFORD, NY, March 04, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), a forward-thinking, publicly-traded company, announces the Board of Directors of Aphex BioCleanse Systems, Inc. has voted in the majority to make the previously announced Suspension of Scott C. Smith, a Director, a permanent termination and for cause. The Board of Directors decision was focused on four primary actions precipitated by Director Scott C. Smith which were determined to be directly unauthorized by the Company and detrimental to the Company and its Shareholders. These actions were:             1. Scott C. Smith did not advise the Board of Directors as to his intention to file a lawsuit. This is in direct contravention with the “Schoon Doctrine”, (Schoon v Smith, No 554, 2006 Del. February 12, 2008.             2. It is the position of Aphex that Scott C. Smith misrepresented himself as the Owner of the key Patents and other Intellectual property relating to Oil Remediation and Open Cell technology. When requested by the Chairman to provide a list of Patents he was representing he would transfer to the Company in return for over 15 million Shares of Company Stock, he refused to comply. Therefore, it is the position of Aphex that Scott C. Smith does not own the key Patents relating to Oil Remediation and open cell technology.             3. It is the position of Aphex that Scott C. Smith has pursued and participated in numerous unauthorized contacts with Company Shareholders and business contacts and has propagated misinformation and unsubstantiated claims against the Company and key Officers and Employees. These actions have substantially damaged the Company.             4. During Scott C. Smith’s association with the Company and as a director and acting Chief Marketing Officer and Chief Sustainability Officer he created expenses but no business and created no revenue for the Company and its shareholders. Accordingly, the Aphex Board of Directors has determined, effective immediately, to permanently terminate Scott C. Smith from any and all duties as a Board Director as well any further representation of Aphex BioClea...

View stock analysis, news, and events for Sunset Capital Assets, Inc.